tle3a Antibody

What is TLE3 and what are its primary functions in cellular regulation?

TLE3 is a member of the transducin-like enhancer of split family that functions as a transcriptional corepressor. It plays critical roles in multiple cellular processes, including:

• Transcriptional regulation through interactions with various transcription factors

• Involvement in Notch signaling pathways that control epithelial cell differentiation

• Acting as a dual-function transcriptional coregulator in adipogenesis

• Maintaining luminal lineage fidelity in breast cancer by repressing genes associated with basal-like breast cancer phenotypes

TLE3 has been implicated in the pathogenesis and classification of several cancer types, notably serving as a candidate biomarker for response to taxane therapy in breast cancer .

To ensure experimental rigor when working with TLE3 antibodies, the following controls are recommended:

• Unstained cells/tissues: Essential to establish baseline autofluorescence levels, particularly important in tissues with high lipid content

• Negative cell population: Utilize cells known not to express TLE3 to confirm antibody specificity. This control is especially important when investigating tissue-specific expression patterns of TLE3

• Isotype control: Include an antibody of the same isotype and host species but with no relevant specificity. This control helps assess Fc receptor-mediated non-specific binding

• Secondary antibody control: When using indirect detection methods, include samples treated only with the labeled secondary antibody to identify non-specific secondary binding

• Knockdown/knockout validation: For definitive specificity confirmation, TLE3 knockdown or knockout samples should be used as negative controls. Several publications have utilized this approach to validate TLE3 antibody specificity

• Blocking peptide competition: Use the immunizing peptide to compete with endogenous TLE3 for antibody binding to confirm signal specificity

What are the recommended dilutions and experimental conditions for TLE3 antibody applications?

Optimal working dilutions for TLE3 antibodies vary by application and specific antibody clone. Based on validated antibodies such as Proteintech 11372-1-AP:

It is strongly recommended to titrate each antibody in your specific experimental system to achieve optimal signal-to-noise ratio. Sample-dependent optimization may be necessary .

What are best practices for TLE3 antibody storage and handling?

For optimal performance and longevity of TLE3 antibodies:

• Store concentrated antibody at -20°C in single-use aliquots to avoid freeze-thaw cycles

• Most commercial TLE3 antibodies are stored in PBS with 0.02% sodium azide and 50% glycerol at pH 7.3

• Antibodies remain stable for approximately one year after shipment when stored properly

• Small volume preparations (20μl) often contain 0.1% BSA as a stabilizer

• When working with the antibody, keep on ice or at 4°C to prevent degradation

• For membrane protein studies, adding 0.1% sodium azide to buffers can prevent internalization of surface antigens

• Always centrifuge antibody vial briefly before opening to collect solution at the bottom of the tube

How can TLE3 immunostaining be optimized for breast cancer biomarker studies?

TLE3 has emerged as a candidate biomarker for response to taxane therapy in breast cancer, requiring specific optimization approaches:

• Tissue preparation: Use formalin-fixed, paraffin-embedded (FFPE) tissue sections cut at 4-5μm thickness

• Antigen retrieval: Critical step for TLE3 detection; use TE buffer at pH 9.0 with high-temperature retrieval (95-98°C for 20 minutes) as the primary method. Citrate buffer at pH 6.0 can be used as an alternative

• Blocking: Intensive blocking (5-10% normal serum) is recommended to reduce background in breast tissue sections

• Antibody incubation: Overnight incubation at 4°C with 1:100 dilution typically provides optimal staining with reduced background

• Counterstaining: Light hematoxylin counterstaining allows better visualization of nuclear TLE3 staining

• Scoring system: Implement a standardized scoring system (e.g., percentage of positive tumor cells multiplied by staining intensity on a 0-3 scale)

In triple-negative breast cancer cohorts, TLE3 staining has been significantly associated with improved 5-year disease-free interval in patients treated with taxane-containing regimens, making standardized staining protocols essential for clinical correlation studies .

What methodologies enable investigation of TLE3's role in transcriptional regulation?

To effectively study TLE3's function as a transcriptional coregulator:

• Chromatin Immunoprecipitation (ChIP):

  • Use optimized fixation (1% formaldehyde for 10 minutes at room temperature)

  • Sonication conditions must be carefully optimized to obtain 200-500bp DNA fragments

  • Validate pulldown with both N-terminal and C-terminal targeting TLE3 antibodies

  • Include appropriate controls (IgG, input chromatin)

  • qPCR primers should target known regulatory regions (e.g., PPARγ-binding sites)

• Co-Immunoprecipitation for Protein Interaction:

  • Investigate interactions with known partners (FOXA1, Wnt pathway components, PPARγ)

  • Nuclear extraction protocols require optimization for efficient TLE3 recovery

  • Use specialized lysis buffers containing 150-420mM NaCl depending on interaction strength

  • Consider crosslinking for transient interactions

• Biophysics-Informed Modeling Approach:

  • Implement computational models that integrate binding data from multiple assays

  • Use data from selection experiments to predict and generate TLE3-interacting variants

  • This approach has successfully identified binding modes associated with specific ligands

• TLE3 Reporter Assays:

  • Develop luciferase reporters containing TLE3-responsive elements

  • Use site-directed mutagenesis to investigate specific binding sites

  • Include both positive (known activators) and negative controls

How can researchers effectively analyze TLE3 expression in adipogenesis studies?

TLE3 plays a critical role in adipogenesis as a dual-function transcriptional coregulator. For robust experimental design:

• Expression Analysis During Differentiation:

  • Monitor TLE3 mRNA expression throughout differentiation timeline using RT-qPCR

  • TLE3 expression rises during differentiation and is enhanced by PPARγ agonist treatment

  • Protein levels should be monitored by western blot with time points at 0, 2, 4, 6, 8, and 10 days of differentiation

• Subcellular Localization:

  • Use confocal immunofluorescence microscopy to visualize TLE3

  • TLE3 colocalizes with DAPI staining, confirming nuclear localization

  • In 10T1/2 cells, TLE3 expression increases robustly in cells induced to differentiate

• Gain and Loss of Function Studies:

  • For knockdown studies, use validated shRNAs targeting TLE3

  • For overexpression, consider stable cell lines expressing TLE3

  • Analyze effects on adipocyte-selective gene expression and morphological differentiation

• PPARγ Pathway Analysis:

  • TLE3 enhances PPARγ-dependent gene induction

  • Combine PPARγ agonist treatment with TLE3 manipulation to dissect the relationship

  • Monitor adipocyte markers and lipid accumulation using Oil Red O staining

What techniques can distinguish TLE3's role in breast cancer subtype maintenance?

To investigate TLE3's function in maintaining luminal breast cancer lineage:

• Subtype-Specific Expression Analysis:

  • Use subtype-classified breast cancer cell lines (luminal vs. basal)

  • Perform immunoblotting with standardized loading controls

  • Quantify TLE3 expression levels using densitometry with normalization to housekeeping proteins

• Transcriptional Repression Mechanisms:

  • Perform RNA-seq after TLE3 knockdown to identify de-repressed genes

  • Focus on genes associated with basal-like breast cancer (BLBC) signatures

  • Validate key targets like SOX9 and TGFβ2 using RT-qPCR

• Protein-Protein Interaction Mapping:

  • Investigate TLE3 interaction with FOXA1 using co-immunoprecipitation

  • Map the domains involved in this interaction using deletion mutants

  • Determine whether these interactions are ER-dependent or independent

• Functional Assays:

  • Assess the impact of TLE3 manipulation on:

    • Epithelial-mesenchymal transition markers

    • Migration and invasion capabilities

    • Metastatic capacity in in vivo models

What are the current challenges and solutions in detecting low-abundance TLE3 in complex samples?

Detecting low levels of TLE3 presents several challenges that can be addressed with advanced techniques:

• Enrichment Strategies:

  • For serum samples, protein G purification can be used to isolate IgG fraction before TLE3 analysis

  • Nuclear extraction protocols should be optimized to concentrate TLE3 from cellular samples

  • Consider using phosphorylation-specific antibodies for analyzing activated forms

• Signal Amplification Methods:

  • Implement tyramide signal amplification for immunohistochemistry

  • Use highly sensitive chemiluminescent substrates for western blotting

  • Consider proximity ligation assay (PLA) for detecting protein-protein interactions involving TLE3

• Mass Spectrometry Approaches:

  • For detecting TLE3 in complex backgrounds, multiple enzymatic digests increase identification probability

  • Region-specific peptide weighting schemes improve detection accuracy

  • Unique CDR3-covering peptides provide higher specificity for antibody characterization

• Limit of Detection Determination:

  • Spike-in experiments with purified TLE3 can establish detection limits in different sample types

  • MS-based proteomics can reliably detect proteins at 0.1% of the total protein concentration

  • Implement rigorous false positive controls and peptide-weighting schemes when analyzing complex samples

How can researchers optimize TLE3 antibody performance in flow cytometry applications?

For successful flow cytometry analysis using TLE3 antibodies:

• Sample Preparation Considerations:

  • Cell fixation and permeabilization are essential as TLE3 is primarily nuclear

  • Use 2-4% paraformaldehyde fixation followed by 0.1% Triton X-100 permeabilization

  • Maintain cell concentration between 10^5-10^6 cells/mL to avoid clogging and ensure good resolution

  • If anticipating cell loss during processing, start with higher cell numbers (10^7 cells/tube)

• Antibody Titration and Validation:

  • Perform careful titration experiments to determine optimal antibody concentration

  • Compare signal in known positive and negative cell populations

  • Validate specificity using siRNA knockdown or CRISPR knockout cells

• Multiparameter Analysis:

  • Include markers for cell cycle analysis as TLE3 expression may vary with cell cycle stage

  • For studying TLE3 in differentiation, combine with lineage-specific markers

  • Use viability dyes to exclude dead cells which may give high background

• Data Analysis Approaches:

  • Implement appropriate gating strategies to identify positive populations

  • Consider median fluorescence intensity rather than percent positive for quantitative analysis

  • Account for autofluorescence through unstained controls and fluorescence-minus-one (FMO) controls

What methodological approaches can identify antibody-specific binding to TLE3 versus other TLE family members?

Distinguishing TLE3 from other TLE family members (TLE1, TLE2, TLE4) requires specific experimental approaches:

• Epitope Mapping and Selection:

  • Select antibodies raised against unique regions of TLE3 not conserved in other family members

  • N-terminal epitopes generally offer better discrimination between TLE family members

  • Consider custom antibody development against unique TLE3 peptide sequences if commercial options lack specificity

• Cross-reactivity Testing:

  • Express individual TLE family members in a heterologous system

  • Test antibody recognition by western blot and immunofluorescence

  • Include competition assays with recombinant proteins to confirm specificity

• Validation in Knockout Systems:

  • Use CRISPR/Cas9 to generate TLE3-specific knockouts

  • Confirm absence of signal with TLE3 antibody while maintaining detection of other TLE family members

  • Rescue experiments with TLE3 expression should restore antibody recognition

• Computational Prediction:

  • Implement biophysics-informed modeling to predict antibody cross-reactivity

  • Analyze sequence similarities between TLE family members in the epitope region

  • Design experiments to test computational predictions of specificity

By implementing these advanced methodological approaches, researchers can ensure their experimental results specifically reflect TLE3 biology rather than contributions from other TLE family members.